Download PDF
Aktuelle Neurologie 2001; 28: 235-241
DOI: 10.1055/s-2001-18910
ORIGINALARBEIT
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Autonome Regulationsstörungen beim idiopathischen Parkinson-Syndrom

Autonomic Dysregulation in Patients with Idopathic Parkinson's DiseaseW.  H. Jost1 , S. Braune2
  • 1Fachbereich Neurologie und Klinische Neurophysiologie der Deutschen Klinik für Diagnostik, Wiesbaden
  • 2Neurologische Universitätsklinik, Freiburg
Further Information

Publication History

Publication Date:
06 December 2001 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Bei vielen Patienten mit einen idiopathischen Parkinson-Syndrom treten im Krankheitsverlauf vegetative Symptome auf. Sie sind gegenüber autonomer Regulationsstörungen bei der Multisystematrophie meist weniger stark ausgeprägt und werden häufig erst im längeren Verlauf symptomatisch. Am ausgeprägtesten zeigen sich die Symptome im kardiovaskulären, gastrointestinalen und urogenitalen Bereich. Durch adäquate Diagnostik und Therapie lässt sich ein erheblicher Nutzen für die Patienten erzielen. Ein interdisziplinäres Vorgehen erweist sich in vielen Fällen als vorteilhaft.

Autonomic Dysregulation in Patients with Idopathic Parkinson's Disease

Most patients with Parkinson's disease experience autonomic dysfunction at some point of their disease course. In contrast to autonomic dysregulation in multisystem atrophy, they are less severe and they frequently cause troublesome symptoms only in advanced stages of the disease. Cardiovascular, gastrointestinal and urogenital autonomic dysfunction is predominant. Appropriate diagnosis and treatment can greatly benefit the patient. An interdisciplinary approach is preferable in most cases.

Literatur

  • 1 Jost W H. Autonome Regulationsstörungen beim Parkinson-Syndrom. Aachen; Shaker-Verlag 1999
    Google Scholar
  • 2 Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. (in Druck)
    Google Scholar
  • 3 Mesec A, Sega S, Kiauta T. The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic response.  Clin Auton Res. 1993;  3 339-344
    CrossrefPubMedGoogle Scholar
  • 4 Micieli G, Martignoni E, Cavallini A. et al . Postprandial and orthostatic hypotension in Parkinson's disease.  Neurology. 1987;  37 386-393
    PubMedGoogle Scholar
  • 5 Turkka J T, Tolonen U, Myllylä V V. Cardiovascular reflexes in Parkinson's disease.  Eur Neurol. 1987;  26 104-112
    PubMedGoogle Scholar
  • 6 Wakabayashi K, Takahashi H, Ohama E. et al . Lewy bodies in the visceral autonomic nervous system in Parkinson's disease.  Adv Neurology. 1993;  60 609-612
    PubMedGoogle Scholar
  • 7 Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease.  Eur Neurol. 1997;  38, Suppl 2 2-7
    PubMedGoogle Scholar
  • 8 Senard J M, Valet P, Durrieu G. et al . Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension.  Eur J Clin Invest. 1990;  20 613-619
    PubMedGoogle Scholar
  • 9 Chaudhuri K R, Ellis C, Love-Jones S. et al . Postprandial hypotension and parkinsonian state in Parkinson's disease.  Mov Disord. 1997;  12 877-884
    CrossrefPubMedGoogle Scholar
  • 10 Braune S, Lücking C H. Orthostatische Hypotonie: Pathophysiologie, Diagnostik, Therapie.  Dtsch Ärztebl. 1997;  94 A 3413-A 3418
    PubMedGoogle Scholar
  • 11 Fischer M, Gemende I, Marsch W C, Fischer P A. Skin function and skin disorders in Parkinson's disease.  J Neural Transm. 2001;  108 205-213
    CrossrefPubMedGoogle Scholar
  • 12 Oppenheim H. Kleine Beiträge zur Neuropathologie.  J Psychol Neurol. 1902;  1 129-146
    PubMedGoogle Scholar
  • 13 Taly A B, Muthane U B. Involvement of peripheral nervous system in juvenile Parkinons's disease.  Acta Neurol Scand. 1992;  85 272-275
    PubMedGoogle Scholar
  • 14 Aminoff M J, Wilcox C S. Assessment of autonomic function in patients with a Parkinsonian syndrome.  Br Med J. 1971;  4 80-84
    PubMedGoogle Scholar
  • 15 Martignoni E, Pacchetti C, Godi L. et al . Autonomic disorders in Parkinson's disease.  J Neural Transm. 1995;  45, Suppl 11-19
    PubMedGoogle Scholar
  • 16 Eadie M J, Tyrer J H. Alimentary disorder in parkinsonism.  Australas Ann Med. 1965;  14 13-22
    PubMedGoogle Scholar
  • 17 Schwab R S, England A C. Parkinson's disease.  J Chron Dis. 1958;  8 488-509
    CrossrefPubMedGoogle Scholar
  • 18 Jost W H. Treatment of drooling in Parkinson's disease with botulinum toxin.  Mov Disord. 1999;  14 1057
    PubMedGoogle Scholar
  • 19 Parkinson J. An essay on the shaking palsy. London; Sherwood, Neely, and Jones 1817
    Google Scholar
  • 20 Bushmann M, Dobmeyer S M, Leeker L. et al . Swallowing abnormalities and their response to treatment in Parkinson's disease.  Neurology. 1989;  39 1309-1314
    CrossrefPubMedGoogle Scholar
  • 21 Edwards L, Quigley E MM, Hofman R. et al . Gastrointestinal symptoms in Parkinson's Disease: 18-month follow-up study.  Mov Disord. 1993;  8 83-86
    CrossrefPubMedGoogle Scholar
  • 22 Nowack W J, Hatelid J M, Sohn R S. Dysphagia in parkinsonism.  Arch Neurol. 1977;  34 320
    PubMedGoogle Scholar
  • 23 Palmer E D. Dysphagia in parkinsonism.  JAMA. 1974;  229 1349
    CrossrefPubMedGoogle Scholar
  • 24 Calne D B, Shaw D G, Spiers A SD. et al . Swallowing in parkinsonism.  Br J Radiol. 1979;  43 456-457
    PubMedGoogle Scholar
  • 25 Korczyn A D. Autonomic nervous system disturbances in Parkinson's disease.  Adv Neurol. 1990;  53 463-468
    PubMedGoogle Scholar
  • 26 Kurlan R, Rubin A J, Miller C. et al . Continuous intraduodenal infusion of levodopa for resistant on-off fluctuations in parkinsonism.  Ann Neurol. 1985;  18 139
    PubMedGoogle Scholar
  • 27 Champion M C. Domperidone.  Gen Pharmac. 1988;  19 499-505
    PubMedGoogle Scholar
  • 28 Parkes J D. Domperidone and Parkinson's disease.  Clin Neuropharmacol. 1986;  9 517-532
    PubMedGoogle Scholar
  • 29 Jost W H, Schimrigk K. Constipation in Parkinson's disease.  Klin Wochenschr. 1991;  69 906-909
    CrossrefPubMedGoogle Scholar
  • 30 Jost W H, Jung G, Schimrigk K. Colonic transit in non - idiopathic Parkinson's syndrome.  Eur Neurol. 1994;  34 329-331
    PubMedGoogle Scholar
  • 31 Ashraf W, Wszolek Z K, Pfeiffer R F. et al . Anorectal function in fluctuating (on-off) Parkinson's disease: evaluation by combined anorectal manometry and electromyography.  Mov Disord. 1995;  10 650-657
    CrossrefPubMedGoogle Scholar
  • 32 Mathers S E, Kempster P A, Law P J. et al . Anal sphincter dysfunction in Parkinson's disease.  Arch Neurol. 1989;  46 1061-1064
    PubMedGoogle Scholar
  • 33 Jost W H. Gastrointestinal motility problems in patients with Parkinson's disease: Effects of antiparkinsonian treatment and guidelines for management.  Drugs & Aging. 1997;  10 249-258
    CrossrefPubMedGoogle Scholar
  • 34 Lewy F H. Zur pathologischen Anatomie der Paralysis agitans.  Dtsch Z Nervenheilk. 1913;  50 50-55
    PubMedGoogle Scholar
  • 35 Andersen J T, Hebjørn S, Frimodt-Møller C. et al . Disturbances of micturition in Parkinson's disease.  Acta Neurol Scand. 1976;  53 161-170
    PubMedGoogle Scholar
  • 36 Raz S. Parkinsonism and neurogenic bladder.  Urol Res. 1976;  4 133-138
    PubMedGoogle Scholar
  • 37 Galloway N TM. Urethral sphincter abnormalities in parkinsonism.  Br J Urol. 1983;  55 691-693
    CrossrefPubMedGoogle Scholar
  • 38 Singer C, Weiner W J, Sanchez-Ramos J R. et al . Sexual dysfunction in men with Parkinson's disease.  J Neuro Rehab. 1989;  3 199-204
    PubMedGoogle Scholar
  • 39 Zesiewicz T A, Helal M, Hauser R A. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease.  Mov Disord. 2000;  15 305-308
    CrossrefPubMedGoogle Scholar

Prof. Dr. med. Wolfgang H. Jost

Fachbereich Neurologie und Klinische Neurophysiologie
Deutsche Klinik für Diagnostik

Aukammallee 33

65191 Wiesbaden

Email: neuro.jost@dkd-wiesbaden.de